#VIVA24: Along with Lorenzo Patrone who is still in transit to Las Vegas, @sternvascular receives the 2024 VCA Award from @VIVAPhysicians. The accolade is given to young physician-leaders for vascular career advancement.
The first patient has been successfully treated with our Esprit BTK Everolimus Eluting Resorbable Scaffold System, pioneering a new standard of care in BTK treatment.
Thanks @PK_MountSinai and team for your commitment to your patients.
Safety Info: https://t.co/twivNLQTJC
Spending the morning with @derubertisMD observing the first commercial Esprit BTK case at Cornell is a great way to start the day. We are excited about what this therapy is bringing to patients. @AbbottCardio#ProudtobeAbbott
Important time for patients suffering the threat of limb loss. Looking forward to the exciting work we have ahead of us in helping to evaluate this technology for our patients. @RamonVarcoeMD@sahilparikhmd
Breaking at #VEITH2019: Announcing the LIFE-BTK pivotal IDE clinical trial to evaluate the safety & effectiveness of ESPRIT BTK, a new everolimus eluting bioresorbable scaffold intended for treating critical limb ischemia!
Read about the #innovativetech:
https://t.co/dPOl4xhRvx